Significance of inhibin in reproductive pathophysiology and current clinical applications

Reproductive BioMedicine Online

Volumn 10, Issue 6, 2005, Pages 786-796

  Kumanov, Philip ^a   Nandipati, Kalyana C ^b   Tomova, Analia ^a   Robeva, Raliza ^a   Agarwal, Ashok ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Activins; Clinical uses; FSH; Inhibins; Pathophysiology

Indexed keywords

ACTIVIN; ALPHA 2 MACROGLOBULIN; CELL MARKER; FOLLISTATIN; FOLLITROPIN; INHIBIN; INHIBIN A; INHIBIN B;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; FEEDBACK SYSTEM; FOLLITROPIN RELEASE; GENITAL SYSTEM DISEASE; GRANULOSA CELL; GRANULOSA CELL TUMOR; HUMAN; HYPOPHYSIS GONAD SYSTEM; INFERTILITY THERAPY; MALE INFERTILITY; MUCINOUS CARCINOMA; NONHUMAN; OVARY CANCER; OVULATION INDUCTION; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREGNANCY; PROGNOSIS; PROSTATE CANCER; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SERTOLI CELL; SPERMATOZOON COUNT; TESTIS SIZE; THECA CELL;

EID: 20444403340     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61124-8     Document Type: Review

References (114)

1. Adamopoulos D, Kapolla N, Nicopoulou S et al. 2003 Assessment of Sertoli cell functional reserve and its relationship to sperm parameters. Inernational Journal of Andrology 26, 215-225.
2. Ala-Fossi SL, Maenpaa J, Blauer M et al. 1998 Inhibin A and B in peri- and postmenopause. Maturitas 30, 273-281.
3. Anawalt BD, Bebb RA, Matsumoto AM et al. 1996 Serum inhibin B concentrations reflect Sertoli cell function in normal men and men with testicular dysfunction. Journal of Clinical Endocrinology and Metabolism 81, 3341-3345.
4. Anderson RA 2001 Clinical studies: inhibin in the adult male. Molecular and Cellular Endocrinology 180, 109-116.
5. Anderson RA, Sharpe RM 2000 Regulation of inbibin production in the human male and its clinical applications. International Journal of Andrology 23, 136-144.
6. Anderson RA, Wallace EM, Groome NP et al. 1997 Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone. Human Reproduction 12, 746-751.
7. Anderson RA, Irvine DS, Balfour C et al. 1998a Inhibin B in seminal plasma: testicular origin and relationship to spermatogenesis. Human Reproduction 13, 920-926.
8. Anderson RA, Evans LW, Irvine DS et al. 1998b Follistatin and activin A production by the male reproductive tract. Human Reproduction 13, 3319-3325.
9. Anderson RA, Groome NP, Baird DT 1998c Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clinical Endocrinology (Oxford) 48, 577-584.
10. Andersson AM 2000 Inhibin B in the assessment of seminiferous tubular function. Baillieres Baillieres Best Practices Research Clinical Endocrinology and Metabolism 14, 389-397.
11. Andersson AM, Juul A, Petersen JH et al. 1997 Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol concentrations. Journal of Clinical Endocrinology and Metabolism 82, 3976-3981.
12. Andersson AM, Muller J, Skakkebaek NE 1998a Different roles of prepubertal and postpubertal germ cells and Sertoli cells in the regulation of serum inhibin B concentrations. Journal of Clinical Endocrinology and Metabolism 83, 4451-4458.
13. Andersson AM, Toppari J, Haavisto AM et al. 1998b Longitudinal reproductive hormone profiles in infants: peak of inhibin B concentrations in infant boys exceeds concentrations in adult men. Journal of Clinical Endocrinology and Metabolism 83, 675-681.
14. Baccarelli A, Morpurgo PS, Corsi A et al. 2001 Activin A serum concentrations and aging of the pituitary-gonadal axis: a cross-sectional study in middle-aged and elderly healthy subjects. Experimental Gerontology 36, 1403-1412.
15. Ballesca JL, Balasch J, Calafell JM et al. 2000 Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia. Human Reproduction 15, 1734-1738.
16. Battistini M, Freeman EW, Grisso JA et al. 2002 Pilot study of racial differences and longitudinal changes in inhibin B in the late reproductive years. Fertility and Sterility 77, 193-195.
17. Bergh A, Cajander S 1990 Immunohistochemical localization of inhibin-alpha in the testes of normal men and in men with testicular disorders. International Journal of Andrology 13, 463-469.
18. Blumenfeld Z, Ritter M 2001 Inhibin, activin, and follistatin in human fetal pituitary and gonadal physiology. Annals of New York Academic Sciences 943, 34-48.
19. Boggess JF, Soules MR, Goff BA et al. 1997 Serum inhibin and disease status in women with ovarian granulosa cell tumors. Gynecology Oncology 64, 64-69.
20. Bohring C, Schroeder-Printzen I, Weidner W et al. 2002 Serum concentrations of inhibin B and follicle-stimulating hormone may predict successful sperm retrieval in men with azoospermia who are undergoing testicular sperm extraction. Fertility and Sterility 78, 1195-1198.
21. Brugo-Olmedo S, De Vincentiis S, Calamera JC et al. 2001 Serum inhibin B may be a reliable marker of the presence of testicular spermatozoa in patients with nonobstructive azoospermia. Fertility and Sterility 76, 1124-1129.
22. Carlsen E, Olsson C, Petersen JH et al. 1999 Diurnal rhythm in serum concentrations of inhibin B in normal men: relation to testicular steroids and gonadotropins. Journal of Clinical Endocrinology and Metabolism 84, 1664-1669.
23. Chada M, Prusa R, Bronsky J, Pechova M et al. 2003 Inhibin B, follicle stimulating hormone, luteinizing hormone, and estradiol and their relationship to the regulation of follicle development in girls during childhood and puberty. Physiological Research 52, 341-346.
24. Chellakooty M, Schmidt IM, Haavisto AM et al. 2003 Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin concentrations in 473 healthy infant girls. Journal of Clinical Endocrinology and Metabolism 88, 3515-3520.
25. Cipriano SC, Chen L, Burns KH et al. 2001 Inhibin and p27 interact to regulate gonadal tumorigenesis. Molecular Endocrinology 15, 985-996.
26. Cooke I, O'Brien M, Charnock FM et al. 1995 Inhibin as a marker for ovarian cancer. British Journal of Cancer 71, 1046-1050.
27. Crofton PM, Evans AE, Groome NP et al. 2002a Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH and testosterone. Clinical Endocrinology (Oxford) 56, 215-221.
28. Crofton PM, Evans AE, Groome NP et al. 2002b Dimeric inhibins in girls from birth to adulthood: relationship with age, pubertal stage, FSH and oestradiol. Clinical Endocrinology (Oxford) 56, 223-230.
29. DePaolo LV, Bicsak TA, Erickson GF et al. 1991 Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proceedings of Society of Experimental Biology and Medicine 198, 500-512.
30. Dzik A, Lambert-Messerlian G, Izzo VM et al. 2000 Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle. Fertility and Sterility 74, 1114-1117.
31. Elting MW, Kwee J, Schats R et al. 2001 The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries. Journal of Clinical Endocrinology and Metabolism 86, 1589-1595.
32. Foresta C, Bettella A, Petraglia F et al. 1999 Inhibin B concentrations in azoospermic subjects with cytologically characterized testicular pathology. Clinical Endocrinology (Oxford) 50, 695-701.
33. Foresta C, Bettella A, Moro E et al. 2001 Sertoli cell function in infertile patients with and without microdeletions of the azoospermia factors on the Y chromosome long arm. Journal of Clinical Endocrinology and Metabolism 86, 2414-2419.
34. Fowler PA, Evans LW, Groome NP et al. 1998 A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy. Human Reproduction 13, 3530-3536.
35. Fried G, Remaeus K, Harlin J et al. 2003 Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization. Journal of Assisted Reproduction and Genetics 20, 167-176.
36. Frydelund-Larsen L, Krausz C, Leffers H et al. 2002 Inhibin B: a marker for the functional state of the seminiferous epithelium in patients with azoospermia factor C microdeletions. Journal of Clinical Endocrinology and Metabolism 87, 5618-5624.
37. Fujisawa M, Dobashi M, Yamasaki T et al. 2001 Significance of serum inhibin B concentration for evaluating improvement in spermatogenesis after varicocelectomy. Human Reproduction 16, 1945-1949.
38. Fujiwara T, Sidis Y, Welt C et al. 2001 Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles. Journal of Clinical Endocrinology and Metabolism 86, 4206-4215.
39. Groome NP, Illingworth PJ, O'Brien M et al. 1996 Measurement of dimeric inhibin B throughout the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism 81, 1401-1405.
40. Hayes FJ, Pitteloud N, DeCruz S et al. 2001 Importance of inhibin B in the regulation of FSH secretion in the human male. Journal of Clinical Endocrinology and Metabolism 86, 5541-5546.
41. Healy DL, Burger HG, Mamers P et al. 1993 Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. New England Journal of Medicine 329, 1539-1542.
42. Hoozemans DA, Schats R, Lambalk CB et al. 2004 Human embryo implantation: current knowledge and clinical implications in assisted reproductive technology. Reproductive BioMedicine Online 9, 692-715.
43. Hutchinson LA, Findlay JK, de Vos FL et al. 1987 Effects of bovine inhibin, transforming growth factor-beta and bovine activin-A on granulosa cell differentiation. Biochemical and Biophysical Research Communications 146, 1405-1412.
44. Iczkowski KA, Bostwick DG, Roche PC et al. 1998 Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors. Modern Pathology 11, 774-779.
45. Illingworth PJ, Groome NP, Byrd W et al. 1996a Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. Journal of Clinical Endocrinology and Metabolism 81, 1321-1325.
46. Illingworth PJ, Groome NP, Duncan WC et al. 1996b Measurement of circulating inhibin forms during the establishment of pregnancy. Journal of Clinical Endocrinology and Metabolism 81, 1471-1475.
47. Jenner AA, de Koning J, van Rees GP 1983 Effect of inhibin-like activity on LH-RH-stimulated release of FSH by pituitary glands from female rats in vitro. Life and Science 32, 1091-1098.
48. Jensen TK, Andersson AM, Hjollund NH et al. 1997 Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone concentrations. A study of 349 Danish men. Journal qf Clinical Endocrinology and Metabolism 82, 4059-4063.
49. Jobling T, Mamers P, Healy DL et al. 1994 A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecology Oncology 55, 285-289.
50. Kamischke A, Simoni M, Schrameyer K et al. 2001 Is inhibin B a pharmacodynamic parameter for FSH in normal men? European Journal of Endocrinology 144, 629-637.
51. Kato T, Seki K, Matsui H, Sekiya S 2002 Circulating inhibin forms in patients with hydatidiform mole. Gynecology Obstetrics Investigations 54, 114-117.
52. Kinniburgh D, Anderson RA 2001 Differential patterns of inhibin secretion in response to gonadotrophin stimulation in normal men. International Journal of Andrology 24, 95-101.
53. Kogawa K, Ogawa K, Hayashi Y et al. 1991 Immunohistochemical localization of follistatin in rat tissues. Endocrinology Japan 38, 383-391.
54. Lambert-Messerlian GM, Saller DN Jr, Tumber MB et al. 1998 Second-trimester maternal serum inhibin A concentrations in fetal trisomy 18 and Turner syndrome with and without hydrops. Prenatal Diagnosis 18, 1061-1067.
55. Lambert-Messerlian GM, DePasquale SE, Maybruck WM et al. 1999 Secretion of activin A in recurrent epithelial ovarian carcinoma. Gynecology and Oncology 74, 93-97.
56. Lebrun JJ, Vale WW 1997 Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. Molecular and Cellular Biology 17, 1682-1691.
57. Lee PA, Coughlin MT, Bellinger MF 2001 Inhibin B: comparison with indexes of fertility among formerly cryptorchid and control men. Journal of Clinical Endocrinology and Metabolism 86, 2576-2584.
58. Lewis KA, Gray PC, Blount AL et al. 2000 Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404, 411-414.
59. Ling N, Ying SY, Ueno N et al. 1986 Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 321, 779-782.
60. Lockwood GM 2000 The role of inhibin in polycystic ovary syndrome. Human Fertility (Camb.) 3, 86-92.
61. Lockwood GM, Ledger WL, Barlow DH et al. 1997 Measurement of inhibin and activin in early human pregnancy: demonstration of fetoplacental origin and role in prediction of early-pregnancy outcome. Biology of Reproduction 57, 1490-1494.
62. Lockwood GM, Muttukrishna S, Groome NP et al. 1998 Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. Journal of Clinical Endocrinology and Metabolism 83, 1730-1735.
63. Mahmoud AM, Comhaire FH, Vereecken A et al. 1996 Inhibin and steroid response to testicular stimulation with pure FSH (Metrodin) in infertile men with unilateral cryptorchidism. Andrologia 28, 103-108.
64. Mahmoud AM, Goemaere S, De Bacquer D et al. 2000 Serum inhibin B concentrations in community-dwelling elderly men. Clinical Endocrinology (Oxford) 53, 141-147.
65. Majdic G, McNeilly AS, Sharpe RM et al. 1997 Testicular expression of inhibin and activin subunits and follistatin in the rat and human fetus and neonate and during postnatal development in the rat. Endocrinology 138, 2136-2147.
66. McCluggage WG 2002 Recent advances in immunohistochemistry in gynaecological pathology. Histopathology 40, 309-326.
67. McCullagh DR 1932 Dual endocrine activity of the testis. Science 76, 19-20.
68. McLachlan RI, Robertson DM, De Kretser DM et al. 1988 Advances in the physiology of inhibin and inhibin-related peptides. Clinical Endocrinology (Oxford) 29, 77-112.
69. Meachem SJ, Nieschlag E, Simoni M 2001 Inhibin B in male reproduction: pathophysiology and clinical relevance. European Journal of Endocrinology 145, 561-571.
70. Meriggiola MC, Noonan EA, Paulsen CA et al. 1996 Annual patterns of luteinizing hormone, follicle stimulating hormone, testosterone and inhibin in normal men. Human Reproduction 11, 248-252.
71. Moore A, Krummen LA, Mather JP 1994 Inhibins, activins, their binding proteins and receptors: interactions underlying paracrine activity in the testis. Molecular and Cellular Endocrinology 100, 81-86.
72. Mottram JC, Cramer W 1923 On the general effects of exposure to radium on metabolism and tumor growth in rat and the special effects on the testis and pituitary. Quarterly Journal of Experimental Physiology and Cognate Medical Sciences 13, 209-229.
73. Munro LM, Kennedy A, McNicol AM 1999 The expression of inhibin/activin subunits in the human adrenal cortex and its tumours. Journal of Endocrinology 161, 341-347.
74. Muttukrishna S 2004 Role of inhibin in normal and high-risk pregnancy. Seminars in Reproductive Medicine 22, 227-234.
75. Muttukrishna S, George L, Fowler PA et al. 1995 Measurement of serum concentrations of inhibin-A (alpha-beta A dimer) during human pregnancy. Clinical Endocrinology (Oxford) 42, 391-397.
76. Muttukrishna S, North RA, Morris J et al. 2000 Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Human Reproduction 15, 1640-1645.
77. Muttukrishna S, Jauniaux E, McGarrigle H et al. 2004 In-vivo concentrations of inhibins, activin A and follistatin in human early pregnancy. Reproductive BioMedicine Online 8, 712-719.
78. Nachtigall LB, Boepple PA, Seminara SB et al. 1996 Inhibin B secretion in males with gonadotropin-releasing hormone (GnRH) deficiency before and during long-term GnRH replacement: relationship to spontaneous puberty, testicular volume, and prior treatment - a clinical research center study. Journal of Clinical Endocrinology and Metabolism 81, 3520-3525.
79. Penarrubia J, Balasch J, Fabregues F et al. 2000 Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment. Human Reproduction 15, 1499-1504.
80. Penarrubia J, Fabregues F, Manau D et al. 2004 Initial analysis of variability among basal hormone biomarkers of ovarian reserve. Reproductive BioMedicine Online 8, 191-195.
81. Petersen PM, Andersson AM, Rorth M et al. 1999a Undetectable inhibin B serum concentrations in men after testicular irradiation. Journal of Clinical Endocrinology and Metabolism 84, 213-215.
82. Petersen PM, Skakkebaek NE, Vistisen K et al. 1999b Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. Journal of Clinical Oncology 17, 941-947.
83. Petraglia F 1997 Inhibin, activin and follistatin in the human placenta - a new family of regulatory proteins. Placenta 18, 3-8.
84. Petraglia F, De Vita D, Gallinelli A et al. 1995 Abnormal concentration of maternal serum activin-A in gestational diseases. Journal of Clinical Endocrinology and Metabolism 80, 558-561.
85. Petraglia F, Luisi S, Pautier P et al. 1998 Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. Journal of Clinical Endocrinology and Metabolism 83, 1029-1032.
86. Pierik FH, Abdesselam SA, Vreeburg JT et al. 2001 Increased serum inhibin B concentrations after varicocele treatment. Clinical Endocrinology (Oxford) 54, 775-780.
87. Risbridger GP, Mellor SL, McPherson SJ et al. 2001 The contribution of inhibins and activins to malignant prostate disease. Molecular and Cellular Endocrinology 180, 149-153.
88. Robertson DM, Foulds LM, Leversha L et al. 1985 Isolation of inhibin from bovine follicular fluid. on granulosa cell differentiation. Biochemical 126, 220-226.
89. Robertson DM, Cahir N, Burger HG et al. 1999 Inhibin forms in serum from postmenopausal women with ovarian cancers. Clinical Endocrinology (Oxford) 50, 381-386.
90. Robertson DM, Stephenson T, Cahir N et al. 2001 Development of an inhibin alpha subunit ELISA with broad specificity. Molecular and Cellular Endocrinology 180, 79-86.
91. Robertson DM, Stephenson T, Pruysers E et al. 2002a Inhibins/activins as diagnostic markers for ovarian cancer. Molecular and Cellular Endocrinology 191, 97-103.
92. Robertson DM, Stephenson T, Pruysers E et al. 2002b Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer. Journal of Clinical Endocrinology and Metabolism 87, 816-824.
93. Salmenkivi K, Arola J, Voutilainen R et al. 2001 Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis. Journal of Clinical Endocrinology and Metabolism 86, 2231-2235.
94. Seifer DB, Lambert-Messerlian G, Hogan JW et al. 1997 Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertility and Sterility 67, 110-114.
95. Seifer DB, Scott RT Jr, Bergh PA et al. 1999 Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertility and Sterility 72, 63-65.
96. Seminara SB, Boepple PA, Nachtigall LB et al. 1996 Inhibin B in males with gonadotropin-releasing hormone (GnRH) deficiency: changes in serum concentration after short-term physiologic GnRH replacement - a clinical research center study. Journal of Clinical Endocrinology and Metabolism 81, 3692-3696.
97. Shelling AN, Burton KA, Chand AL et al. 2000 Inhibin: a candidate gene for premature ovarian failure. Human Reproduction 15, 2644-2649.
98. Spencer SJ, Rabinovici J, Mesiano S et al. 1992 Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells. Journal of Clinical Investigation 90, 142-149.
99. Tanabe K, Saijo A, Park JY et al. 1990 The role of inhibin in women with polycystic ovary syndrome (PCOS). Hormonal Research 33 (Suppl. 2), 10-17.
100. Tinkanen H, Blauer M, Laippala P et al. 1999 Prognostic factors in controlled ovarian hyperstimulation. Fertility and Sterility 72, 932-936.
101. Vale W, Rivier J, Vaughan J et al. 1986 Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321, 776-779.
102. von Eckardstein S, Simoni M, Bergmann M et al. 1999 Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. Journal of Clinical Endocrinology and Metabolism 84, 2496-2501.
103. Voutilainen R 1995 What is the function of adrenal inhibins? European Journal of Endocrinology 132, 290-291.
104. Voutilainen R, Eramaa M, Ritvos O 1991 Hormonally regulated inhibin gene expression in human fetal and adult adrenals. Journal of Clinical Endocrinology and Metabolism 73, 1026-1030.
105. Wallace EM, D'Antona D, Shearing C et al. 1999 Amniotic fluid concentrations of dimeric inhibins, pro-alpha C inhibin, activin A and follistatin in Down's syndrome. Clinical Endocrinology (Oxford) 50, 669-673.
106. Wallace EM, Crossley JA, Groome NP et al. 1997a Amniotic fluid inhibin-A in chromosomally normal and Down's syndrome pregnancies. Journal of Endocrinology 152, 109-112.
107. Wallace EM, Groome NP, Riley SC et al. 1997b Effects of chemotherapy-induced testicular damage on inhibin, gonadotropin, and testosterone secretion: a prospective longitudinal study. Journal of Clinical Endocrinology and Metabolism 82, 3111-3115.
108. Wallace EM, Marjono B, Tyzack K et al. 2004 First trimester concentrations of inhibins and activin A in normal and failing pregnancies. Clinical Endocrinology (Oxford) 60, 484-490.
109. Welt CK 2002 The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction. Current Opinion in Obstetrics and Gynecology 14, 317-323.
110. Wong CH, Mruk DD, Siu MK et al. 2005 Blood-testis barrier dynamics are regulated by alpha2-macroglobulin via the c-Jun N-terminal protein kinase pathway. Endocrinology 146, 1893-1908.
111. Ying SY 1987 Inhibins and activins: chemical properties and biological activity. Proceedings of the Society of Experimental Biology and Medicine 186, 253-264.
112. Yohkaichiya T, Fukaya T, Hoshiai H et al. 1989 Inhibin: a new circulating marker of hydatidiform mole? British Medical Journal 298, 1684-1686.
113. Young J, Couzinet B, Chanson P et al. 2000 Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. Journal of Clinical Endocrinology and Metabolism 85, 3239-3244.
114. Zheng W, Senturk BZ, Parkash V 2003 Inhibin immunuhistochemical staining: a practical approach for the surgical pathologist in the diagnoses of ovarian sex cord-stromal tumors. Advances in Anatomy and Pathology 10, 27-38.